The Effects of Vitamin D Supplementation on Aerobic Fitness in Athletes

NCT02278172 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2016-05-25

No results posted yet for this study

Summary

The primary aim of the study is to identify if vitamin D3 supplementation influences VO2max in athletes.

Secondary aims are to determine if vitamin D3 supplementation impacts on measures of muscle function, lung function, body composition, immune function and the self-reported incidence of upper respiratory tract infection.

This double-blind, randomised, placebo-controlled trial is of parallel design and will aim to recruit a total of 50 athletes randomised into either a placebo or treatment group for a 12-week intervention.

Conditions

  • Aerobic Fitness (VO2max)

Interventions

DIETARY_SUPPLEMENT

Vitamin D

3000IU (75 μg) vitamin D in a commercially available oral spray solution

DIETARY_SUPPLEMENT

Placebo

Placebo oral spray solution manufactured to mimic the vitamin D oral spray

Sponsors & Collaborators

  • Northern Ireland Executive

    collaborator UNKNOWN
  • University of Ulster

    lead OTHER

Principal Investigators

  • Pamela J Magee, PhD · University of Ulster

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278172 on ClinicalTrials.gov